Park Ha Biological Technology Co., Ltd. (BYAH)
NASDAQ: BYAH · Real-Time Price · USD
1.040
-0.040 (-3.70%)
Apr 29, 2026, 10:52 AM EDT - Market open
BYAH Revenue
In the fiscal year ending October 31, 2025, Park Ha Biological Technology had annual revenue of $2.52M with 6.00% growth. Park Ha Biological Technology had revenue of $1.29M in the half year ending October 31, 2025, with 18.22% growth.
Revenue (ttm)
$2.52M
Revenue Growth
+6.00%
P/S Ratio
0.90
Revenue / Employee
$61,582
Employees
41
Market Cap
2.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 2.52M | 142.99K | 6.00% |
| Oct 31, 2024 | 2.38M | -77.25K | -3.14% |
| Oct 31, 2023 | 2.46M | 539.71K | 28.12% |
| Oct 31, 2022 | 1.92M | 988.35K | 106.16% |
| Oct 31, 2021 | 931.04K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yatsen Holding | 614.51M |
| SkinHealth Systems | 300.79M |
| European Wax Center | 206.63M |
| Acme United | 202.88M |
| Grove Collaborative Holdings | 173.72M |
| Solesence | 62.06M |
| Tantech Holdings | 41.98M |
| United-Guardian | 10.55M |
BYAH News
- 3 months ago - Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering - GlobeNewsWire
- 6 months ago - Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH - GlobeNewsWire
- 1 year ago - Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering - GlobeNewsWire
- 1 year ago - Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering - GlobeNewsWire